<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03057171</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-0146</org_study_id>
    <nct_id>NCT03057171</nct_id>
  </id_info>
  <brief_title>A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA</brief_title>
  <official_title>A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helicobacter pylori (H.pylori) is a major human pathogenic bacterium in gastric mucosa which
      is linked to the development of gastritis, peptic ulcer disease, mucosa-associated lymphoid
      tissue lymphoma and gastric cancer. However the regulatory mechanism of H.pylori-induced
      immune response is not clear. Long non-coding RNA (lncRNA) has recently emerged as key
      post-transcriptional regulators of gene expression, differentiation. The investigators had a
      preliminary results which THRIL (TNFÎ± and hnRNPL related immunoregulatory lincRNA) and
      PACER(p50-associated COX-2 extragenic RNA) played a potential role in H.pylori induced
      inflammatory cascade. However, there wasn't a previous study about expression of THRIL, PACER
      in a human tissue. Therefore, the investigators aimed to evaluate the expression of THRIL,
      PACER in patients with gastrointestinal disease according to H.pylori infection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of THRIL, PACER</measure>
    <time_frame>Within 2 weeks after EGD</time_frame>
    <description>Expression of THRIL, PACER according to Helicobacter pylori infection by Real-time aRT-PCR</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <condition>Gastric Ulcer</condition>
  <condition>Duodenal Ulcer</condition>
  <condition>Stomach Cancer</condition>
  <arm_group>
    <arm_group_label>Gastric ulcer</arm_group_label>
    <description>patients who will undergo EGD for gastric ulcer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Duodenal ulcer</arm_group_label>
    <description>patients who will undergo EGD for duodenal ulcer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stomach cancer</arm_group_label>
    <description>patients who will undergo EGD for stomach cance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>health individuals</arm_group_label>
    <description>patients who will undergo screening EGD</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EGD, forcep biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with gastrointestinal disease associated with H.pylori infection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Over 19 years old

          2. Patients with gastric ulcer

          3. Patients with duodenal ulcer

          4. Patients with stomach cancer

          5. Patients with gastrointestinal discomfort symptoms

        Exclusion Criteria:

          1. Patients who has done helicobacter pylori eradication

          2. Patients who has undergone gastrectomy

          3. Patients who has undergone endoscopic submucosal dissection

          4. Patients with active upper gastrointestinal bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sang Kil Lee, MD</last_name>
    <phone>82-2-2228-1996</phone>
    <email>sklee@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yonsei university College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Kil Lee, MD</last_name>
      <phone>82-2-2228-1996</phone>
      <email>sklee@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2017</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Helicobacter pylori</keyword>
  <keyword>long non-coding RNA</keyword>
  <keyword>THRIL</keyword>
  <keyword>PACER</keyword>
  <keyword>cagA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Stomach Ulcer</mesh_term>
    <mesh_term>Duodenal Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

